Injectable-Grade Excipients & Solubility-Enhancing Technologies Market
完整報告名稱與涵蓋範圍
Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Size, Share & Trends Analysis Report, By Excipient Type (Cyclodextrins and Complexation Agents, Co-Solvents, Surfactants and Lipid-Based Solubilizers, Buffers, Stabilizers and Tonicity Agents, Polymers for Controlled-Release Injectables, Bio-Derived and Sustainable Injectable Excipients), By Function (Solubility and Bioavailability Enhancement, Protein Stabilization, Controlled and Extended Release, Sterility, pH and Tonicity Control), By Application (Small-Molecule Injectables, Biologics and Peptides, Vaccines and Nucleic Acid Therapeutics), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The injectable-grade excipients and solubility-enhancing technologies market covers high-purity excipients and enabling formulation technologies used in parenteral products, including cyclodextrins and complexation agents, co-solvents, surfactants and lipid-based solubilizers, buffers and stabilizers for proteins, polymers for controlled-release depots and the emerging class of bio-derived and sustainably sourced injectable excipients. Oral excipients and active ingredients are excluded, as is the finished injectable product market.
Demand is being driven by the growing share of poorly soluble small molecules, the expansion of biologics, peptides and nucleic acid therapeutics that require sophisticated stabilisation, and the shift toward long-acting injectables that rely on polymer and lipid matrices. Cyclodextrin technology has become a mainstream solution for solubility-limited injectables, while animal-origin-free, low-endotoxin and low-metal grades address regulatory and quality expectations. Sustainability programs are prompting suppliers to introduce plant-derived and lower-carbon excipients with full traceability, and novel excipient review pathways are beginning to reduce the historical barrier to adopting new materials.
North America and Europe lead consumption of premium injectable grades, and Asia Pacific is expanding both production and demand alongside biologics and generic injectable manufacturing. Competition includes specialty excipient producers, chemical groups with pharmaceutical divisions and technology licensors of proprietary solubilization platforms.
The InsightAce study includes revenue forecasts in US$ for all excipient type, function, application and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Snapshot
Chapter 4. Global Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Excipient Type Estimates & Trend Analysis
5.1. Excipient Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Excipient Type:
5.2.1. Cyclodextrins and Complexation Agents
5.2.2. Co-Solvents, Surfactants and Lipid-Based Solubilizers
5.2.3. Buffers, Stabilizers and Tonicity Agents
5.2.4. Polymers for Controlled-Release Injectables
5.2.5. Bio-Derived and Sustainable Injectable Excipients
Chapter 6. Market Segmentation 2: By Function Estimates & Trend Analysis
6.1. Function & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Function:
6.2.1. Solubility and Bioavailability Enhancement
6.2.2. Protein Stabilization
6.2.3. Controlled and Extended Release
6.2.4. Sterility, pH and Tonicity Control
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Small-Molecule Injectables
7.2.2. Biologics and Peptides
7.2.3. Vaccines and Nucleic Acid Therapeutics
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical Manufacturers
8.2.2. CDMOs
8.2.3. Biotechnology Companies
Chapter 9. Injectable-Grade Excipients & Solubility-Enhancing Technologies Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Roquette Freres
11.2. Ligand Pharmaceuticals (Captisol)
11.3. Cyclolab Ltd.
11.4. Wacker Chemie AG
11.5. Evonik Industries AG
11.6. Croda International Plc
11.7. BASF SE
11.8. Merck KGaA
11.9. DFE Pharma
11.10. Lipoid GmbH
11.11. Gattefosse SAS
11.12. Nippon Fine Chemical Co., Ltd.
11.13. Ashland Inc.
11.14. Pfanstiehl, Inc.
11.15. IOI Oleo GmbH
圖表清單 List of Tables & Figures
Table 1. Global Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Revenue Forecast by Excipient Type, 2026-2035 (US$ Mn)
Figure 1. Global Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Segmentation Overview
Table 2. Global Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Revenue Forecast by Function, 2026-2035 (US$ Mn)
Figure 2. Global Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Share by Excipient Type, 2026 & 2035
Table 3. Global Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Injectable Excipient Selection Across Small Molecules, Biologics and Nucleic Acid Therapeutics
Table 4. Global Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Share by Function, 2026 & 2035
Table 5. North America Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Cyclodextrin and Lipid-Based Solubilization Technology Adoption in Approved Injectables
Table 6. Europe Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Injectable-Grade Excipients & Solubility-Enhancing Technologies Growth Opportunity Analysis
Table 7. Asia Pacific Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Sustainable and Bio-Derived Excipient Introductions and Regulatory Acceptance Pathways
Table 8. Latin America Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Participants
Table 9. Middle East & Africa Injectable-Grade Excipients & Solubility-Enhancing Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們